Communiqués MeiraGTx Holdings plc

Actions

MGTX

KYG596651029

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
4,86 ^USD	+5,42 %		+20,60 %	-30,77 %

12/06	Transcript : MeiraGTx Holdings plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 02:40 PM
15/05	Transcript : MeiraGTx Holdings plc Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

MeiraGTx Reports First Quarter 2024 Financial and Operational Results	09/05	GL
MeiraGTx : Results of a Phase 1, Open-label, Dose-escalation Study of Gene Therapy with AAV2-hAQP1 as Treatment for Grade 2 and 3 Radiation-induced Late Xerostomia and Parotid Gland Hypofunction – The AQUAx Study	02/05	PU
MeiraGTx to Participate in Upcoming Investor Conferences	24/04	GL
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference	18/04	GL
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates	14/03	GL
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	13/02	GL
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	13/02	AQ
Progress In Preventing Blindness	26/01	AQ
Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors	03/01	AQ
MeiraGTx sells XLRP gene therapy to Janssen	22/12	AQ
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million	21/12	GL
MeiraGTx to Participate in Upcoming Investor Conferences	21/11	GL
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results	14/11	GL
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results	14/11	AQ
BestGrowthStocks.Com: MeiraGTx Holdings plc Actively Pursuing Strategic Partnerships and Asset Interest, Potential Transactions	31/10/23	AQ
MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities	30/10/23	GL
MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress	24/10/23	GL
MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress	24/10/23	AQ
Janssen to Highlight Latest Advances in Retina Portfolio at the European Society of Retina Specialists 2023 Annual Meeting	04/10/23	AQ
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results	10/08/23	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués MeiraGTx Holdings plc

Actions

MGTX

KYG596651029

Communiqués

Filtres